Showing results (281-290 of 513) with videos related to

Sort By:
Pageof 52
Oncology|December 23, 2024
Adjuvant Sequential Chemotherapy for Salivary Duct Carcinomas: A Retrospective Comparative AnalysisYounghac Kim, Nayeon Choi, Eun-Hye Kim, et al.
Head & Neck|June 25, 2015
Effect of induction chemotherapy on survival in locally advanced head and neck squamous cell carcinoma treated with concurrent chemoradiotherapy: Single center experienceChan-Young Ock, Bhumsuk Keam, Yoojoo Lim, et al.
Cancer Medicine|December 1, 2022
Transcriptional upregulation of CXCL13 is correlated with a favorable response to immune checkpoint inhibitors in lung adenocarcinomaSehhoon Park, Hongui Cha, Hong Sook Kim, et al.
Cancer Research and Treatment|July 22, 2015
VEGF and Ki-67 Overexpression in Predicting Poor Overall Survival in Adenoid Cystic CarcinomaSeongyeol Park, Soo Jeong Nam, Bhumsuk Keam, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 9, 2018
Characteristics and Outcome of ROS1-Positive Non-Small Cell Lung Cancer Patients in Routine Clinical PracticeSehhoon Park, Beung-Chul Ahn, Sung Won Lim, et al.
Cancer|June 18, 2016
Efficacy and safety of dovitinib in pretreated patients with advanced squamous non-small cell lung cancer with FGFR1 amplification: A single-arm, phase 2 studySung Hee Lim, Jong-Mu Sun, Yoon-La Choi, et al.
Oncotarget|May 27, 2015
Mechanism for enhanced 5-aminolevulinic acid fluorescence in isocitrate dehydrogenase 1 mutant malignant gliomasJa Eun Kim, Hye Rim Cho, Wen Jun Xu, et al.
Radiation Oncology Journal|January 8, 2024
Pulmonary function and toxicities of proton versus photon for limited-stage small cell lung cancerSang Hoon Seo, Hongryull Pyo, Yong Chan Ahn, et al.
JCO Precision Oncology|May 9, 2024
Clinical Validation of Artificial Intelligence-Powered PD-L1 Tumor Proportion Score Interpretation for Immune Checkpoint Inhibitor Response Prediction in Non-Small Cell Lung CancerHyojin Kim, Seokhwi Kim, Sangjoon Choi, et al.
British Journal of Cancer|January 31, 2018
Pazopanib maintenance after first-line etoposide and platinum chemotherapy in patients with extensive disease small-cell lung cancer: a multicentre, randomised, placebo-controlled Phase II study (KCSG-LU12-07)Jong-Mu Sun, Ki Hyeong Lee, Bong-Seog Kim, et al.
Pageof 52